ESC 365 - Absorb bioresorbable scaffold vs. Xience metallic stent: outcomes in the AIDA trial stratified by SYNTAX score

ESC Premium Access

Absorb bioresorbable scaffold vs. Xience metallic stent: outcomes in the AIDA trial stratified by SYNTAX score

Session: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Topic: Outcome

Speaker: Mr R. Kraak (Amsterdam, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Mr Robin Paul Kraak

Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))

0 follower

26 more presentations in this session

Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free biolimus A9-coated stent: insights from the all-comers FREEDOM registry

Speaker: Doctor G. Gallone (Turin, IT)

Long term clinical outcome of a novel sirolimus-eluting coronary stent in patients with acute myocardial infarction

Speaker: Doctor S. Dani (Ahmedabad, IN)

Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

Speaker: Doctor H. Matsuda (Nagoya, JP)

Clinical outcomes of an ultra-thin strut sirolimus-eluting stent with biodegradable polymer in all-comers patients undergoing coronary intervention

Speaker: Doctor I. Menown (Craigavon, GB)

Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents

Speaker: Miss L. Kerkmeijer (Zwolle, NL)

Access the full session

Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

Speakers: Mr R. Kraak, Doctor G. Gallone, Doctor S. Dani, Doctor H. Matsuda, Doctor I. Menown...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources